Author:
Vos Larissa J,Janoski Michele,Wachowicz Keith,Yahya Atiyah,Boychak Oleksandr,Amanie John,Pervez Nadeem,Parliament Matthew B,Pituskin Edith,Fallone B Gino,Usmani Nawaid
Publisher
Baishideng Publishing Group Inc.
Reference33 articles.
1. Canadian Cancer Society. Canadian cancer statistics 2014. Available from: http: //www.cancer.ca/~/media/cancer.ca/CW/publications/Canadian Cancer Statistics 2014/Canadian-Cancer-Statistics-2014-EN.pdf.
2. Draisma G, Boer R, Otto SJ, van der Cruijsen IW, Damhuis RA, Schröder FH, de Koning HJ. Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. J Natl Cancer Inst 2003;95:868-878.
3. Chen J, Zhao Y, Li X, Sun P, Wang M, Wang R, Jin X. Imaging primary prostate cancer with 11C-Choline PET/CT: relation to tumour stage, Gleason score and biomarkers of biologic aggressiveness. Radiol Oncol 2012;46:179-188.
4. Klotz L. Active surveillance for favorable risk prostate cancer: what are the results, and how safe is it? Semin Radiat Oncol 2008;18:2-6.
5. Klotz L. Active surveillance for prostate cancer: overview and update. Curr Treat Options Oncol 2013;14:97-108.
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献